Halozyme Announces FDA Approval Of Herceptin Hylecta
Halozyme Therapeutics, Inc., a biotechnology company developing novel oncology and drug-delivery therapies, announced that Genentech, a member of the Roche Group, has received approval...
CRISPR and Vertex treat first patient in gene-editing therapy trial
Swiss gene editing company CRISPR Therapeutics and US-based Vertex Pharmaceuticals have started treating patients in a Phase I/II clinical trial of an investigational gene-editing...
PPD and HLT to Create Data Science-Driven Clinical Research Solutions in China to Enhance Global Drug Development
Pharmaceutical Product Development, LLC and Happy Life Tech of China have signed an exclusive agreement to develop a distinctive service offering for the China...
Aucta Pharmaceuticals and Oakrum Pharma Announce Product Development and Commercialization Partnership
Aucta Pharmaceuticals, Inc. (Aucta) announced that it has entered into an agreement with Oakrum Pharma, LLC (Oakrum) to develop and manufacture four prescription generic...
Emerald Health and Lonza Enter Large-Scale Manufacturing Pact
Emerald Health Pharmaceuticals and Lonza have entered an agreement for the large-scale manufacturing of a new synthetic derivative of cannabidiol (CBD) and its oral...
Shimmer Launches Verisense Wearable Sensor Platform for Clinical Trials
Shimmer, a global leader in wearable technology for research applications, announced the launch of Verisense, its next-generation wearable sensor platform designed from the ground...
Knight Therapeutics invests up to $125m in Latin America-focused Moksha8
Canada-based Knight Therapeutics has announced it has closed a strategic financing agreement of up to $125m with US-headquartered Moksha8, which specialises in licensing and...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...